Watch Webinar Replay: Thursday, March 10th 2022 @ 11:00AM AEDT

This webinar will examine these challenges and explore which key decision-making factors are important when considering an in-house effort vs outsourcing to a partner. In this presentation, Andrew Campitelli will address these issues with the goal of helping diagnostic stakeholders make better decisions toward the growth of their diagnostic programs.

WATCH EVENT PLAYBACK >

Speaker: Tamma M. Kaysser-Kranich, Ph.D.
VP, Chief Technology Officer, Applied Microarrays

Recorded: Lab-on-Chip & Microfluidics Congress, Coronado CA

I'll cover two main topics in this talk. I’ll spend a little bit of time introducing Applied Microarrays, in case you are not familiar with our capabilities. I’ll go also some the exciting evolution in our own business in becoming part of SCHOTT MINIFAB and what that means for what we can offer to IVD design development and manufacturing. 

Whether you are developing a glass biochip for inhouse use, or as a commercial product, cost-of-good (COGs) has always been at the top of consideration list. Key to managing COGs is the ability to keep costs as low as possible in small quantities whilst still taking advantage of economy of scale as demand increases. This is particularly challenging with customized glass chips.

Watch Free Wen Session
LIVE recorded on Wednesday, November 10th 2021

Join leading experts in microfluidic polymer and glass diagnostics for this deep dive into microfluidic diagnostics development. The two sessions blend commercial and technical subjects across IVD manufacturing and microarray development.

High-precision 3D-glass components for diagnostics

We are happy to announce that the joint project between SCHOTT Technical Glass Solutions GmbH, LensTec Jena GmbH and the Fraunhofer Insitute for Applied Optics and Precision Engineering IOF is receiving support from the European Regional Development Fund.

28 September 2021, Germany, Mainz

  • The acquisition of the Arizona-based microarray solutions company extends SCHOTT’s manufacturing presence in the United States and strengthens its bioscience capabilities.
  • Customers will benefit from enhanced development and manufacture capabilities including high-density microarray printing.
Page 1 of 3